XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Common Stock to be Issued
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 1,273 $ 5 $ 17,342,559 $ (16,761,512) $ 582,325
Balance (in Shares) at Dec. 31, 2020 12,727,820 52,782      
Sale of common stock, net of offering costs $ 40 1,592,932 1,592,972
Sale of common stock, net of offering costs (in Shares) 403,024 1,675      
Common stock issued for common stock issuable $ 5 $ (5)
Common stock issued for common stock issuable (in Shares)   51,018 (51,143)      
Common stock issued for services $ 21 469,979 470,000
Common stock issued for services (in Shares)   205,000        
Net loss for the period (996,771) (996,771)
Balance at Mar. 31, 2021 $ 1,339 19,405,470 (17,758,283) 1,648,526
Balance (in Shares) at Mar. 31, 2021 13,386,862 3,314      
Balance at Dec. 31, 2020 $ 1,273 $ 5 17,342,559 (16,761,512) 582,325
Balance (in Shares) at Dec. 31, 2020 12,727,820 52,782      
Net loss for the period           (1,642,550)
Balance at Jun. 30, 2021 $ 1,339 19,500,735 (18,404,062) 1,098,012
Balance (in Shares) at Jun. 30, 2021 13,389,083 1,389      
Balance at Mar. 31, 2021 $ 1,339 19,405,470 (17,758,283) 1,648,526
Balance (in Shares) at Mar. 31, 2021 13,386,862 3,314      
Common stock to be issued cancelled (1,000) (1,000)
Common stock to be issued cancelled (in Shares) (250)      
Accretion of stock-based compensation 100,000 100,000
Fractional shares due to reverse split
Fractional shares due to reverse split (in Shares) 21      
Sale of common stock, net of offering costs (3,735) (3,735)
Sale of common stock, net of offering costs (in Shares) 525      
Common stock issued for common stock issuable
Common stock issued for common stock issuable (in Shares) 1,675 (1,675)      
Net loss for the period (645,779) (645,779)
Balance at Jun. 30, 2021 $ 1,339 19,500,735 (18,404,062) 1,098,012
Balance (in Shares) at Jun. 30, 2021 13,389,083 1,389      
Balance at Dec. 31, 2021 $ 1,960 47,672,600 (27,590,546) 20,084,014
Balance (in Shares) at Dec. 31, 2021 19,597,419 1,389      
Accretion of stock based compensation in connection with stock option grants 822,583 822,583
Accretion of stock-based professional fees in connection with stock option grants and shares 202,275 202,275
Net loss for the period (3,365,846) (3,365,846)
Balance at Mar. 31, 2022 $ 1,960   48,697,458 (30,956,392) 17,743,026
Balance (in Shares) at Mar. 31, 2022 19,597,419 1,389      
Balance at Dec. 31, 2021 $ 1,960 47,672,600 (27,590,546) 20,084,014
Balance (in Shares) at Dec. 31, 2021 19,597,419 1,389      
Net loss for the period           (5,947,558)
Balance at Jun. 30, 2022 $ 2,060 50,594,839 (33,538,104) 17,058,795
Balance (in Shares) at Jun. 30, 2022 20,597,419 1,389      
Balance at Mar. 31, 2022 $ 1,960   48,697,458 (30,956,392) 17,743,026
Balance (in Shares) at Mar. 31, 2022 19,597,419 1,389      
Accretion of stock based compensation in connection with stock option grants 772,197   772,197
Accretion of stock-based professional fees in connection with stock option grants and shares 35,284 35,284
Shares issued for asset acquisition $ 100 1,089,900 1,090,000
Shares issued for asset acquisition (in Shares) 1,000,000      
Net loss for the period (2,581,712) (2,581,712)
Balance at Jun. 30, 2022 $ 2,060 $ 50,594,839 $ (33,538,104) $ 17,058,795
Balance (in Shares) at Jun. 30, 2022 20,597,419 1,389